Routine Genital Herpes Serologic Testing Not Recommended: USPSTF Reaffirms

Published Date: 17 Feb 2023

United States: The USPSTF advised against serological testing for the genital herpes simplex virus (HSV) in an advisory...

Read Full News

Latest News

His Research on Pregnant Opioid Users Was Celebrated. Experts Found Major Flaws.

Some clinics still use approaches described in Craig Towers' research

Study Offers Reassurance on Inhaled Corticosteroid Use for Asthma in Pregnancy

— Asthma has been linked with adverse outcomes in both mothers and their offspring

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

Some clinics still use approaches described in Craig Towers' research

— Asthma has been linked with adverse outcomes in both mothers and their offspring

Latest Breakthroughs in Antibody-Drug Conjugates for Endometrial Cancer: Insights From Recent Oncology Meetings

Optimizing Treatment Persistence and Patient Outcomes Through Evidence-Based ADC-Associated Adverse Event Management by APPs on the Frontlines of Care

Integrating Biomarker-Driven First-Line Maintenance Therapies in Advanced Ovarian Cancer

Ascent to Evidence-Based ADC Integration: Real-World Strategies to Shape the Destiny of mBC Care

News All Time

Experts Establish Pillars of Care for Older Adults With HIV

ART iniitiation, managing comorbidities addressed for aging patients

In Lindsay Clancy's Tragedy, I Recognize Something Painfully Familiar

A better model of care is urgently needed for postpartum mental health

Lindsay Clancy's Diary Chronicled Desperation and 'Brain Fog' Before She Killed Kids

"I want help. I want to be well," her attorney read from one journal entry

A Week After Shaving, She Developed Rare Flesh-Eating Disease

Fournier's gangrene followed a perineal shave and application of cream from an alternative healer

Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

"PD-L1 is clinically useful but imperfect," expert says

Woman Says She Was Wrongly Diagnosed With Cancer, Had Surgery Due to Labeling Error

Atlanta-area patient filed lawsuit against the medical center

Residential Context Matters in Ovarian Cancer Survival

That's especially true for Black women

Debate on Use of SSRIs in Pregnancy Shifting, Experts Say

Researchers push for a focus on shared structured decision-making processes

Infants Possibly Exposed to HIV via Breast Milk Donated Over Social Media

Potentially exposed babies tracked down by investigators all tested negative

The Doctors Who 'Don't See Pregnant Patients'

Neither pregnancy nor abortion are siloed

Threat Monitoring, Legal Resources: How Hospitals Adapted to Abortion Bans

Institutional standards necessary to give physicians clarity, says researcher

This Fetus Had a Parasitic Twin in an Unusual Location

Extremely rare palatal fetus-in-fetu proved challenging for medical team

Her Vagina Burned Every Time She Ate Spicy Food

Case report details pain caused when capsaicin seeps past hardened fecal stones in fistula

ACOG Strengthens Support for Fallopian Tube Removal to Prevent Ovarian Cancer

Bilateral salpingectomy reduces risk by as much as 78%; consider during nongynecologic surgery

Lindsay Clancy's Defense Rests After Postpartum Psychosis Testimony

Closing arguments expected next week

Ousting RFK Jr. Among the Priorities for This Doctor Running for Senate

— South Carolina pediatrician also calls for a public option and to end extreme abortion bans

Recommended News For You

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Microplastics can cause malignant changes in lung cells

Smartphone App Detects Eye Cancers From Photos

A single bout of exercise gives results that could help cancer patients

Children with rare gliomas have new hope thanks to clinical trial results.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

Recommended Articles For You

Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology 

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results 

Risk Assessment of Bone-Marrow Reserve Under Repeated Physiological Demands 

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer

2.

Gatekeeping May Reduce Pediatric Cancer Trial Participation

3.

Research team uncovers the underpinnings of head and neck cancers

4.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

5.

Resection for Early Liver Cancer Tied to Improved Survival.

1.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

2.

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide

3.

The Unseen Danger of Anal Cancer: How to Protect Yourself

4.

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells

5.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Navigating the Complexities of Ph Negative ALL - Part VIII

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

5.

Navigating the Complexities of Ph Negative ALL - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot